CClinicalTrials.gg
CompletedNCT07611292Updated May 28, 2026

Periodontal Biocompatibility of Pediatric Crowns

An observational study in Oral Health, Pediatric Dentistry and Stainless-steel Crown, sponsored by Recep Tayyip Erdogan University Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-28.

Sponsored by Recep Tayyip Erdogan University Training and Research Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
21
Ages
6 Years to 9 Years
Sex
All
01

Study summary

Different full-coverage crown materials are widely used in pediatric dentistry for the restoration of primary teeth with extensive substance loss. Since these restorations remain in close contact with gingival tissues for prolonged periods, they may influence periodontal health depending on their surface characteristics, marginal adaptation, and biological properties. The aim of this study was to evaluate the effects of stainless steel crowns (SSC), prefabricated zirconia crowns (PZC), and fiber-glass crowns (FGC) on periodontal health in children using both clinical periodontal parameters and gingival crevicular fluid (GCF) biomarkers, including IL-1β and MMP-8, within a split-mouth study design.

02

Conditions studied

  • Oral Health
  • Pediatric Dentistry
  • Stainless-steel Crown
  • Matrix Metalloproteinase
  • Periodontal Health

Keywords

  • oral health
  • pediatric dentistry
  • periodontal health
03

In context

Lead sponsor

Recep Tayyip Erdogan University Training and Research Hospital is the lead sponsor of 85 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

children who applied for the dental treatment to the Faculty of Dentistry in Rize

Inclusion criteria

  • Children who were aged between 6 and 9 years
  • Children had a score of 3 or 4 on the Frankl Behavioral Scale
  • Children had an indication for full coronal restoration in the primary second molars in all the three quadrants
  • Presence of extensive or chronic carious lesions involving the pulp with radiographic scores ranging between 2 and 3
  • Presence of localized hypoplastic defects
  • Normal or non-resorbed interproximal bone levels, defined radiographically as a distance of no more than 2 mm between the interdental bone crest and the cementoenamel junction
  • Those where the root resorption level was blunt or the apex was rounded, and those where 1/4 of the root has been resorbed

Exclusion criteria

Exclusion Criteria:

  • Children had any systemic disease
  • History of allergy to local anesthetic agents, nickel, or resin-based restorative materials
  • Extremely poor oral hygiene
  • Periodontal disease
  • Malocclusion
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
21 participants (actual)
Target follow-up
2 Months
Patient registry
Yes
Biospecimen retention
Samples without dna

Groups and cohorts

  • Group 1

    Teeth diagnosed with an indication for full coronal restoration and treated with stainless steel crown.

    Other: Clinical periodontal assessments, GCF measurements and sample collection

  • Group 2

    Teeth diagnosed with an indication for full coronal restoration and treated with prefabricated zirconia crown.

    Other: Clinical periodontal assessments, GCF measurements and sample collection

  • Group 3

    Teeth diagnosed with an indication for full coronal restoration and treated with fiber glass crown.

    Other: Clinical periodontal assessments, GCF measurements and sample collection

  • Group 4

    Healthy primary molars (control group)

    Other: Clinical periodontal assessments, GCF measurements and sample collection

Interventions

  • OtherClinical periodontal assessments, GCF measurements and sample collection

    Clinical periodontal assessments were carried out for all participants at baseline (T0), as well as during the third-month (T1) and sixth-month (T2) follow-up visits. The clinical periodontal status was assessed with the probing pocket depth (PPD), bleeding on probing (BOP), plaque index (PI), and gingival index (GI). For each patient, GCF measurements and sample collection were performed at baseline (T0), as well as during the third-month (T1) and sixth-month (T2) visits. MMP-8 and IL-1β analyses were performed on GCF samples by the enzyme-linked immunosorbent assay (ELISA).

06

What researchers measure

Primary outcomes

  1. assessment of probing pocket depth (PPD)

    probing pocket depth (PPD) was measured the distance between the gingival margin and the deepest point of the sulcus. PPD was evaluated from six surfaces (mesiobuccal, midbuccal, distobuccal, mesiolingual/mesiopalatal, midlingual/midpalatal, and distolingual/distopalatal) of the teeth. The measurements were done utilizing a Williams periodontal probe.

    Time frame: From beginning to the end of treatment at 6 months

  2. assessment of matrix metalloproteinase-8 (MMP-8) level in gingival crevicular fluid (GCF)

    MMP-8 was performed on GCF samples by the enzyme-linked immunosorbent assay (ELISA) in the Medical Biochemistry Research and Application Laboratory of the Recep Tayyip Erdogan University Faculty of Medicine. Twenty-four hours before the assay procedure, the eppendorf tubes were removed from the deep freezer and allowed to thaw progressively at -20 °C followed by +4 °C. Prior to analysis, both the samples and assay reagents were equilibrated to room temperature (18-25 °C). Each GCF specimen was analyzed individually without combining the samples. The results were expressed in ng/mL (MMP-8).

    Time frame: in the sixth month (after sample collection was complete)

  3. Assessment of bleeding on probing (BOP)

    Bleeding on probing (BOP) scores were obtained from four surfaces (mesial, distal, buccal, and palatal/lingual) of the primary second molars. The measurements were done utilizing a Williams periodontal probe.

    Time frame: From beginning to the end of treatment at 6 months

  4. Assessment of plaque index (PI)

    Plaque index (PI) scores were obtained from four surfaces (mesial, distal, buccal, and palatal/lingual) of the primary second molars. The measurements were done utilizing a Williams periodontal probe.

    Time frame: From beginning to the end of treatment at 6 months

  5. Assessment of Gingival index (GI)

    Gingival index (GI) scores were obtained from four surfaces (mesial, distal, buccal, and palatal/lingual) of the primary second molars. The measurements were done utilizing a Williams periodontal probe.

    Time frame: From beginning to the end of treatment at 6 months

  6. Assessment of interleukin-1 beta (IL-1β) level in gingival crevicular fluid (GCF)

    In GCF samples taken from patients, IL-1β level was determined by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions at the Medical Biochemistry Research and Application Laboratory of Recep Tayyip Erdoğan University Faculty of Medicine. Twenty-four hours before the assay procedure, the eppendorf tubes were removed from the deep freezer and allowed to thaw progressively at -20 °C followed by +4 °C. Prior to analysis, both the samples and assay reagents were equilibrated to room temperature (18-25 °C). Each GCF specimen was analyzed individually without combining the samples. The results were expressed in pg/mL (IL-1β).

    Time frame: in the sixth month (after sample collection was complete)

07

Study locations

1 site
  • Sema Aydinoglu
    Rize, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07611292
Lead sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Responsible party
Sema Aydınoglu (associated professor, Recep Tayyip Erdogan University Training and Research Hospital) — Principal investigator
First posted
May 28, 2026
Start date
Jun 30, 2024
Primary completion
Dec 30, 2025
Completion
Apr 20, 2026
Last update
May 28, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion